COVID-19 Stroke Apical Lung Examination Study: A Diagnostic and Prognostic Imaging Biomarker in Suspected Acute Stroke

^aFrom the Department of Neuroradiology (J.S., F.B., T.C.B.), King’s College Hospital, National Health Service Foundation Trust, London, UK
^bLysholm Department of Neuroradiology (S.S., A.M.F., I.D.), National Hospital for Neurology and Neurosurgery, University College London Hospitals, National Health Service Foundation Trust, London, UK
^cDepartment of Neurology (M.B., L.K.S.), King’s College Hospital, National Health Service Foundation Trust, London, UK
^dDepartment of Neurosurgery (S.A.M.), National Hospital for Neurology and Neurosurgery, University College London Hospitals, National Health Service Foundation Trust, London, UK
^eDepartment of Radiology (F.N.A.C.M.), King’s College Hospital, National Health Service Foundation Trust, London, UK
^fComprehensive Stroke Service (R.J.S., I.C.), University College London Hospitals, National Health Service Foundation Trust, London, UK
^gStroke Research Centre (R.J.S.), University College London Queen Square Institute of Neurology, London, UK
^hBrain Repair and Rehabilitation Unit (I.D.), University College London Queen Square Institute of Neurology, London, UK
ⁱSchool of Biomedical Engineering and Imaging Sciences (T.C.B.), King’s College London, Rayne Institute, St. Thomas’ Hospital, London, UK

Please address correspondence to Thomas C. Booth, PhD, School of Biomedical Engineering and Imaging Sciences, King's College London, Rayne Institute, 4th Floor, Lambeth Wing, St. Thomas’ Hospital, London SE1 7EH, UK; e-mail: thomas.booth{at}kcl.ac.uk; @ThomasCBooth